Plain English Summary
Background and study aims
Tuberculosis is a major cause of morbidity and mortality. Pulmonary Rehabilitation includes exercise training, education and behaviour change support and has been successfully employed in health care institutions to improve the quality of life in patients with chronic lung disease. Little is known about the effect of Pulmonary Rehabilitation on patients living with Tuberculosis. In order for Pulmonary Rehabilitation to be successful, patient buy-in or motivation is important to ensure patient uptake and completion is maximised. Furthermore, the specific details surrounding a culturally appropriate Pulmonary Rehabilitation programme are unknown. Information will be collected from patients that are suitable for attending Pulmonary Rehabilitation regards their opinions and perceptions, to optimise uptake in a culturally appropriate Pulmonary Rehabilitation programme. Similarly, it is important that the healthcare workers support the implementation of a clinical Pulmonary Rehabilitation programme. At present, the awareness and opinions of healthcare workers in Kyrgyzstan is unknown. Collecting this data will enhance the implementation of a Pulmonary Rehabilitation programme in Kyrgyzstan.
Who can participate?
Patients diagnosed with post-tuberculosis lung disease or healthcare professionals working with patients with chronic respiratory disease
What does the study involve?
Participants will answer a questionnaire on their attitudes and opinions regarding Pulmonary Rehabilitation
What are the possible benefits and risks of participating?
Benefits of participation are to contribute to informing the need for and potential design of pulmonary rehabilitation in Kyrgyzstan. There are no risks to participation.
Where is the study run from?
1. National Center of Cardiology and Internal Medicine Kyrgyzstan
2. Bishkek City TB Hospital Kyrgyzstan
When is the study starting and how long is it expected to run for?
April 2018 to March 2021
Who is funding the study?
National Institute for Health Research (NIHR), UK
Who is the main contact?
Dr Mark Orme
mwo4@leicester.ac.uk
Trial website
Contact information
Type
Public
Primary contact
Dr Mark Orme
ORCID ID
http://orcid.org/0000-0003-4678-6574
Contact details
Centre for Exercise and Rehabilitation Science
NIHR Leicester Biomedical Research Centre- Respiratory
Glenfield Hospital
Groby Road
Leicester
LE3 9QP
United Kingdom
+44 (0)1162583113
mwo4@leicester.ac.uk
Type
Scientific
Additional contact
Dr Mark Orme
ORCID ID
http://orcid.org/0000-0003-4678-6574
Contact details
Centre for Exercise and Rehabilitation Science
NIHR Leicester Biomedical Research Centre- Respiratory
Glenfield Hospital
Groby Road
Leicester
LE3 9QP
United Kingdom
+441162583113
mwo4@leicester.ac.uk
Additional identifiers
EudraCT number
Nil known
ClinicalTrials.gov number
Nil known
Protocol/serial number
Version 1
Study information
Scientific title
The attitudes and opinions of healthcare staff and patients living with post-tuberculosis lung disease regards the delivery of a clinical pulmonary rehabilitation programme: Global RECHARGE Kyrgyzstan
Acronym
Global RECHARGE Kyrgyzstan (Survey)
Study hypothesis
Despite being a common treatment for chronic lung disease in high income countries, Pulmonary Rehabilitation is not often implemented in low and middle income countries. Data is needed surrounding the perspectives and opinions of medical staff and patients living with chronic lung disease regards implementing and creating a clinical Pulmonary Rehabilitation service.
Ethics approval
Approved 16/09/2019, University of Leicester Ethics Committee (The University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom; +44 (0)1162522522; ethicsapp@leicester.ac.uk), ref: 22293
Study design
Multi-centre observational cross-sectional trial
Primary study design
Observational
Secondary study design
Cross sectional study
Trial setting
Hospitals
Trial type
Other
Patient information sheet
Not available in web format, please use contact details to request a participant information sheet
Condition
Post-tuberculosis lung disease
Intervention
This is a questionnaire study that will seek to collect the attitudes and opinions on of participants living with post-TB lung disease and health-care professionals regarding pulmonary rehabilitation. Participants will be asked to complete a questionnaire only. There is no follow-up for this study.
Intervention type
Other
Phase
Drug names
Primary outcome measure
The questionnaire data will be used to:
1. Understand the patients' enthusiasm for Pulmonary Rehabilitation and their preference regards delivery mode
2. Understand the attitudes and beliefs of potential referrers to Pulmonary Rehabilitation and how they might best like to receive information and refer patients into the service
Secondary outcome measures
The questionnaire data will be used to:
1. Determine the need for Pulmonary Rehabilitation from patients with chronic lung disease
2. Obtain information on the mode of Pulmonary Rehabilitation that is acceptable to patients
3. Obtain information on the attitudes and beliefs of health care providers who would be potential referrers to Pulmonary Rehabilitation
4. Obtain the views of health care personnel on transfer of information and the mode of referral to the Pulmonary Rehabilitation service
5. Collect preliminary anonymous questionnaire data from potential candidates with chronic lung disease and healthcare workers on the need for Pulmonary Rehabilitation and their individual preferred modes of delivery
Overall trial start date
01/04/2018
Overall trial end date
31/03/2021
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
1. Patients diagnosed with post-tuberculosis lung disease, or
2. Healthcare professionals working with patients with chronic respiratory disease
Participant type
Mixed
Age group
Adult
Gender
Both
Target number of participants
60
Total final enrolment
214
Participant exclusion criteria
Anyone unable to provide written informed consent
Recruitment start date
17/09/2019
Recruitment end date
01/11/2019
Locations
Countries of recruitment
Kyrgyzstan
Trial participating centre
National Center of Cardiology and Internal Medicine
3 Togolok Moldo Street
Bishkek
720040
Kyrgyzstan
Trial participating centre
Bishkek City TB Hospital
211 Elebesov Street
Bishkek
720040
Kyrgyzstan
Sponsor information
Organisation
University of Leicester
Sponsor details
University road
Leicester
LE1 7RH
United Kingdom
+44 (0)1162522522
smd8@leicester.ac.uk
Sponsor type
University/education
Website
Funders
Funder type
Government
Funder name
National Institute for Health Research
Alternative name(s)
NIHR
Funding Body Type
government organisation
Funding Body Subtype
National government
Location
United Kingdom
Results and Publications
Publication and dissemination plan
It is anticipated that the results from this study will be published in international journals and presented locally, nationally and internationally at appropriate meetings and conferences. All data that will be collected is anticipated to be published.
IPD sharing statement
The data sharing plans for the current study are unknown and will be made available at a later date/
Intention to publish date
31/03/2021
Participant level data
To be made available at a later date
Basic results (scientific)
Publication list